The therapeutic advantages of OXT and its analogs in treating obesity and diabetes can be further increased given that OXT has social-neuropsychiatric benefits which can possibly aid to control metabolic disease. The gene discussed is OXT; the disease is obesity due to melanocortin 4 receptor deficiency.